ePrints

Future directions in the pharmacology of anti-cancer agents in children

Lookup NU author(s): Professor Andrew Pearson

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

In the 1990s, over two-thirds of children with malignancy are expected to be long term survivors. This success in therapy is predominantly due to the chemosensitivity of childhood tumours as well as co-ordinated multi-disciplinary care through the use of protocols and designated children's cancer centres, in view of the pivotal importance of chemotherapy in childhood malignancies in the future therapy can be improved considerably by exploring ways to optimise treatment either by introducing new agents or utilising existing drugs better.

Publication metadata

Author(s): Pearson ADJ

Publication type: Article

Publication status: Published

Journal: British Medical Bulletin

Year: 1996

Volume: 52

Issue: 4

Pages: 844-872

Print publication date: 01/10/1996

ISSN (print): 0007-1420

ISSN (electronic): 1471-8391

URL: http://bmb.oxfordjournals.org/cgi/content/abstract/52/4/844

PubMed id: 9039736

Share